Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bulbo-Spinal Atrophy, X-Linked × Aromatase Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 64 Polycystic Ovary Syndrome 3 Neoplasms, Hormone-Dependent 3 Neoplasm Metastasis 3 Arthralgia 3 Advanced Breast Cancer 3 Osteoporosis 2 Fractures, Bone 2 Endometrial Neoplasms 2 Carcinoma, Lobular 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Breast Cancer Female 2 Sexuality 1 Neurotoxicity Syndromes 1 Luminal B/HER2-negative Breast Cancer 1 Leiomyoma 1 Infertility 1 Hormone-receptor-positive Breast Cancer 1 Hormone Receptor Positive Breast Carcinoma 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 Fatigue 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Bone Diseases, Metabolic 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

bicalutamide 4 enzalutamide 3 exemestane 2 darolutamide 2 abiraterone 2 pembrolizumab 1 ostarine 1 nilutamide 1 cabazitaxel 1 apalutamide 1 abemaciclib 1 Vorinostat 1 Triptorelin Pamoate 1 Tamoxifen 1 Prophylactic Mastectomy 1 Prednisolone 1 Mifepristone 1 Letrozole 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Goserelin 1 Doxorubicin 1 Docetaxel 1 Dasatinib 1 Cisplatin 1 CP protocol 1 Aromatase Inhibitors 1 Antiemetics 1 Anastrozole 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02910050 2017-12-22

BETTER

Sun Yat-sen University

Phase 2 Unknown

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡